Caas Capital Management LP Dyne Therapeutics, Inc. Transaction History

Caas Capital Management LP

  • $836 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$15.94 - $22.33 $344,877 - $483,131
-21,636 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$14.0 - $29.3 $2.3 Million - $4.81 Million
-164,275 Reduced 88.36%
21,636 $336,000
Q4 2020

Feb 12, 2021
BUY
$16.81 - $23.94 $2.94 Million - $4.19 Million
174,911 Added 1590.1%
185,911 $3.9 Million
Q3 2020

Nov 09, 2020
BUY
$20.0 - $23.9 $220,000 - $262,900
11,000 New
11,000 $222,000

Others Institutions Holding DYN

# of Institutions
210
Shares Held
102M
Call Options Held
234K
Put Options Held
238K
View Full List

About Dyne Therapeutics, Inc.

DYN Quotes by TradingView
  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.55B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email